Health and Fitness Health and Fitness
Mon, November 9, 2009
[ Mon, Nov 09th 2009 ] - Market Wire
SciClone Reports Financial Results and Provides C .. nd Pipeline Updates for the Third Quarter of 2009
[ Mon, Nov 09th 2009 ] - Market Wire
Angiotech Pharmaceuticals, Inc. announces financi .. ts for the third quarter ended September 30, 2009
[ Mon, Nov 09th 2009 ] - Market Wire
Cypress Bioscience Announces Third Quarter 2009 Financial Results
[ Mon, Nov 09th 2009 ] - Market Wire
Syneron Reports Third Quarter 2009 Financial Results
Fri, November 6, 2009
[ Fri, Nov 06th 2009 ] - Market Wire
Cardiome to Release Third Quarter Results
[ Fri, Nov 06th 2009 ] - Market Wire
Hypertension Diagnostics Announces First Quarter Fiscal Year 2010 Results
[ Fri, Nov 06th 2009 ] - Market Wire
Stellar Pharmaceuticals' Q3-2009 Financial Result .. rked by Strong Growth and Continued Profitability
[ Fri, Nov 06th 2009 ] - Market Wire
First Transcatheter Valve Cases in Japan Performed With Edwards SAPIEN Valve
[ Fri, Nov 06th 2009 ] - Market Wire
Oncolytics Biotech(R) Inc. Collaborators Present .. e II Sarcoma Trial Results at CTOS Annual Meeting
[ Fri, Nov 06th 2009 ] - Market Wire
Metro One Development Prepares for Ad Sales
[ Fri, Nov 06th 2009 ] - Market Wire
Agennix AG Shares Begin Trading on Frankfurt Stock Exchange
Thu, November 5, 2009
[ Thu, Nov 05th 2009 ] - Market Wire
Centric Health reports solid 2009 third quarter financial results
[ Thu, Nov 05th 2009 ] - Market Wire
Theravance and Astellas Announce the Commercial L .. of VIBATIV(TM) (telavancin) in the United States
[ Thu, Nov 05th 2009 ] - Market Wire
DIAGNOS Announces the Sale of the Harricana North Property to North American Palladium Ltd
[ Thu, Nov 05th 2009 ] - Market Wire
Oncolytics Biotech(R) Inc. Announces 2009 Third Quarter Results
Wed, November 4, 2009
[ Wed, Nov 04th 2009 ] - Market Wire
Premium Brands Holdings Corporation Announces Third Quarter 2009 Conference Call
[ Wed, Nov 04th 2009 ] - Market Wire
Given Imaging Reports Third Quarter 2009 Results
[ Wed, Nov 04th 2009 ] - Market Wire
Chembio Reports Third Quarter 2009 Results
[ Wed, Nov 04th 2009 ] - Market Wire
Allana Resources Announces $2 Million Private Pla .. -Take/ Financing Deal With a Chinese Mining Group
[ Wed, Nov 04th 2009 ] - Market Wire
Edwards Lifesciences to Present at the Credit Suisse Annual Healthcare Conference
[ Wed, Nov 04th 2009 ] - Market Wire
Depression Treatments Reviewed by NeuroInvestment
[ Wed, Nov 04th 2009 ] - Market Wire
MMR Information Systems Engages Global Research S .. ate Time to Market for Anti-CD20 Monoclonal Antib
[ Wed, Nov 04th 2009 ] - Market Wire
Amador Gold Corp. Commences Drilling on Horwood Gold Property in West Timmins District
[ Wed, Nov 04th 2009 ] - Market Wire
Meridian Medical Sales Distribution Expands in Key East Coast Markets
[ Wed, Nov 04th 2009 ] - Market Wire
Leatt Corporation Wins 2009 Product Innovation Award From Freeride Magazine
[ Wed, Nov 04th 2009 ] - Market Wire
Northstar Healthcare Announces Complete Resolution to Dispute with Major Payor
[ Wed, Nov 04th 2009 ] - Market Wire
Remedent to Present FirstFit, a Revolutionary Sol .. owns, at the Den-Mat Education Destination Semina
[ Wed, Nov 04th 2009 ] - Market Wire
ImmuCell Announces Financial Results for Third Quarter of 2009
[ Wed, Nov 04th 2009 ] - Market Wire
Cipher reports Q3 2009 financial results
[ Wed, Nov 04th 2009 ] - Market Wire
&;AElig;terna Zentaris to Announce Third Quarter .. ancial and Operating Results on November 11, 2009

&;AElig;terna Zentaris to Announce Third Quarter 2009 Financial and Operating Results on November 11, 2009


Published on 2009-11-04 04:05:54 - Market Wire
  Print publication without navigation


QUÉBEC CITY, Nov. 4 /CNW Telbec/ - Æterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ) (the "Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, will announce its third quarter 2009 financial and operating results before market open on Wednesday, November 11, 2009. The Company will host a conference call and webcast to discuss these results later that same day at 10:00 a.m., Eastern Time.

Participants may access the live webcast via the Company's website at [ www.aezsinc.com ] in the "Investors" section, or by telephone using the following numbers: 877-974-0453, 416-644-3431, or 514-227-8860. A replay of the webcast will also be available on the Company's website for a period of 30 days.

About Æterna Zentaris Inc.

Æterna Zentaris Inc. is a global biopharmaceutical company focused on endocrine therapy and oncology with proven expertise in drug discovery, development and commercialization. News releases and additional information are available at [ www.aezsinc.com ].

Contributing Sources